BioMarin Pharmaceutical, Inc. (BMRN)
61.80
-0.82
(-1.31%)
USD |
NASDAQ |
Feb 25, 14:07
BioMarin Pharmaceutical Price : 61.80 for Feb. 25, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amicus Therapeutics, Inc. | 14.34 |
| Gilead Sciences, Inc. | 147.25 |
| Merck & Co., Inc. | 122.38 |
| AbbVie, Inc. | 226.75 |
| Bristol Myers Squibb Co. | 61.04 |
Price Related Metrics
| PE Ratio | 34.69 |
| PS Ratio | 3.731 |
| Price to Book Value | 1.951 |
| Price to Free Cash Flow | 16.76 |
| Earnings Yield | 2.88% |
| Market Cap | 11.87B |
| Operating PE Ratio | 15.08 |
| Normalized PE Ratio | 19.41 |